Skip to main content
. 2023 Oct 31;30(10):1776–1787. doi: 10.1093/ibd/izad245

Figure 3.

Figure 3.

Adjusted rate of switching or discontinuation of first- and second-line biologics. aBonferroni adjusted. Abbreviations: ADA, adalimumab; CI, confidence interval; IFX, infliximab; NA, not applicable; UST, ustekinumab; VDZ, vedolizumab.